Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118729784 | 11872978 | 4 | F | 20160708 | 20151228 | 20160718 | PER | US-PFIZER INC-2015469495 | PFIZER | 50.00 | YR | F | Y | 0.00000 | 20160718 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118729784 | 11872978 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | UNK | U | M40020 | 21446 | CAPSULE, HARD | |||||||
| 118729784 | 11872978 | 2 | SS | LYRICA | PREGABALIN | 1 | 150 MG, 3X/DAY | U | 21446 | 150 | MG | CAPSULE, HARD | TID | ||||||
| 118729784 | 11872978 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | U | M40020 | 21446 | 150 | MG | CAPSULE, HARD | TID | ||||
| 118729784 | 11872978 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | ||||||||
| 118729784 | 11872978 | 5 | C | ACETAMINOPHENHYDROCODONE BITARTRATE | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 10 MG, AS NEEDED (EVERY 4 HOURS ) | 0 | 10 | MG | ||||||||
| 118729784 | 11872978 | 6 | C | LISINOPRIL-HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Oral | 1 DF, DAILY [20-25 MG] | 0 | 1 | DF | TABLET | |||||||
| 118729784 | 11872978 | 7 | C | METHOCARBAMOL. | METHOCARBAMOL | 1 | Oral | UNK UNK, AS NEEDED | 0 | TABLET | |||||||||
| 118729784 | 11872978 | 8 | C | METHOCARBAMOL. | METHOCARBAMOL | 1 | Oral | 750 MG, UNK [Q 8 HRS PM] | 0 | 750 | MG | TABLET | |||||||
| 118729784 | 11872978 | 9 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 1 MG, 3X/DAY | 0 | 1 | MG | TABLET | TID | ||||||
| 118729784 | 11872978 | 10 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK (AS DIRECTED) | 0 | ||||||||||
| 118729784 | 11872978 | 11 | C | TAMOXIFEN | TAMOXIFEN | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118729784 | 11872978 | 1 | Breast cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118729784 | 11872978 | Drug effect incomplete | |
| 118729784 | 11872978 | Malaise | |
| 118729784 | 11872978 | Nasopharyngitis | |
| 118729784 | 11872978 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118729784 | 11872978 | 2 | 20091123 | 0 | ||
| 118729784 | 11872978 | 3 | 20160624 | 0 | ||
| 118729784 | 11872978 | 6 | 20140616 | 0 | ||
| 118729784 | 11872978 | 7 | 20160606 | 0 | ||
| 118729784 | 11872978 | 8 | 20140818 | 0 | ||
| 118729784 | 11872978 | 9 | 20160606 | 0 | ||
| 118729784 | 11872978 | 10 | 20151222 | 0 | ||
| 118729784 | 11872978 | 11 | 20140428 | 0 |